How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
It's an upgrade worth making, but it comes down to your privacy concerns.
As organizations race to adopt artificial intelligence, the conversation has increasingly shifted from raw model performance ...
4d
Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...
Autonomous AI post-training reached frontier scale for the first time: NVIDIA researchers published a paper showing an AI ...
The frontier model is a commodity. The companies winning are the ones that own distribution, and venture capital is paying up ...
This week’s cybersecurity recap covers Firefox and Chrome bugs, EDR-killer tools, a TV botnet, an OpenBSD flaw, Android ...
MCP, Skills, and Claude Projects create a three-layer AI stack that transforms marketing from copy-paste workflows to live ...
A single missing feature in Bitcoin Script has spawned twelve competing proposals. Cointelegraph Research gives an overview. With the recent diversification of consensus clients into Core and Knots ...
Abstract: Haze reduces the visibility of image content and leads to failure in handling subsequent computer vision tasks. In this paper, we address the problem of single image dehazing by proposing a ...
Nvidia CEO Jensen Huang (R) and SK Group Chairman Chey Tae-won (L) hand out "HBM chip" snacks to reporters during their dinner at a Korean barbecue restaurant in Seoul on June 5, 2026. Nvidia chief ...
Building a model capable of RSI would require automating a range of specialist tasks currently carried out by humans. At present data scientists work on the theory of AI and coders put it into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results